Table 5.
MiRNAs expressed in xenograft passages of A) Case 430 primary tumor while absent in lung metastasis, 12 miRNAs, B) Case 430 lung metastasis while absent in primary tumor, 18 miRNAs and C) Case 430 primary tumors and control, while absent in lung metastasis, 11 miRNAs
miRNAs expressed in | |||
---|---|---|---|
A) Xenograft passages from Primary tumor (12 miRNAs) | B) Xenograft passages from lung metastasis (18 miRNAs) | C) Control and xenograft passages from Primary tumor (11 miRNAs) | |
hsa-miR-1237 | hsa-miR-1183 | hsa-miR-595 | hsa-miR-154* |
hsa-miR-139-3p | hsa-miR-124 | hsa-miR-601 | hsa-miR-214* |
hsa-miR-139-5p | hsa-miR-1471 | hsa-miR-623 | hsa-miR-337-3p |
hsa-miR-202 | hsa-miR-32* | hsa-miR-662 | hsa-miR-34a* |
hsa-miR-30b* | hsa-miR-424* | hsa-miR-664* | hsa-miR-369-5p |
hsa-miR-450a | hsa-miR-486-3p | hsa-miR-671-5p | hsa-miR-409-5p |
hsa-miR-490-3p | hsa-miR-520b | hsa-miR-411 | |
hsa-miR-501-5p | hsa-miR-520e | hsa-miR-485-3p | |
hsa-miR-502-5p | hsa-miR-96 | hsa-miR-487a | |
hsa-miR-548 d-5p | hsa-miR-877 | hsa-miR-542-3p | |
hsa-miR-602 | hsa-miR-95 | hsa-miR-770-5p | |
hsa-miR-885-5p | hsa-miR-765 |